Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Munster – page 63

809 clinical trials in Munster, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Munster at a glance
809
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

809 trials in Munster

Open in trial search

Oesophageal carcinoma

Not recruiting

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Merck Sharp & Dohme LLC

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Back pain

Not recruiting

Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Fungal infection

Not recruiting

Study on Rezafungin Acetate for Children with Fungal Infections Aged Birth to Under 18 Years

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Rezafungin Acetate
  • Sponsor:Mundipharma Research Limited

Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Buserelin Acetate
  • Sponsor:Friedrich-Schiller-Universitaet Jena

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Neoplasm malignant

Not recruiting

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer Consumer Care AG

Portal hypertension

Not recruiting

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Cardiac amyloidosis

Not recruiting

Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Ionis Pharmaceuticals Inc.

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Regentree LLC

Other cities in Germany

The busiest research cities in the country

All 504 cities in Germany

Clinical research in Munster

What the registry says about research in the country

01 Oncology & Hematology

Advanced research focusing on lymphoma treatments and innovative therapies for breast cancer and lung cancer. Studies include evaluations of new combinations of targeted therapies and immunotherapy approaches.

  • Diffuse Large B-Cell Lymphoma
  • Advanced Breast Cancer
  • Non-Small Cell Lung Cancer
  • Acute Myeloid Leukemia

Several trials are exploring novel treatment combinations and maintenance therapies for various blood cancers.

02 Metabolic & Cardiovascular Disorders

Comprehensive studies addressing obesity management and cardiovascular disease prevention. Research includes innovative approaches for weight management and heart failure risk reduction.

  • Obesity Treatment
  • Type 2 Diabetes
  • Heart Failure Prevention
  • Cardiovascular Risk Management

Multiple trials are investigating new therapeutic options for weight management and cardiovascular health improvement.

03 Dermatology & Immunology

Innovative research in treating chronic skin conditions including plaque psoriasis and hidradenitis suppurativa. Studies focus on novel biological therapies and targeted treatments.

  • Moderate to Severe Plaque Psoriasis
  • Hidradenitis Suppurativa
  • Chronic Rhinosinusitis

Trials are evaluating next-generation treatments for inflammatory skin conditions and immune-mediated disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.